Exploring the Impact of Malnutrition-Associated Symptom Groups on Quality of Life in Patients with Nasopharyngeal Carcinoma Undergoing Radiotherapy: A Network Analysis - Summary - MDSpire

Exploring the Impact of Malnutrition-Associated Symptom Groups on Quality of Life in Patients with Nasopharyngeal Carcinoma Undergoing Radiotherapy: A Network Analysis

  • By

  • Meng-Yu Hao

  • Feng-Yan Li

  • Su-Man Zhang

  • Yu-Xian Yang

  • Yu-Xi Xiong

  • Hang-Yu Wang

  • Yao Zhuang Chuah

  • Zi-Hang Chen

  • Ling-Xin Xu

  • Peng Sun

  • Jian Ji

  • Lecheng Jia

  • Hua Li

  • Yanfei Liu

  • Ying Sun

  • Jia-Wei Lv

  • Yan Li

  • Guan-Qun Zhou

  • February 13, 2026

  • 0 min

Share

Objective:

To depict the current real-world burdens of acute toxicities during all radiotherapy phases and determine symptom clusters and their network relationships with malnutrition and quality of life, specifically addressing the implications for patient care.

Key Findings:
  • Malnutrition is prevalent among NPC patients undergoing radiotherapy and is linked to symptom burden, highlighting the need for targeted interventions.
  • Symptom clusters identified include gastrointestinal, psychological, and cancer-specific symptoms, which may require integrated management strategies.
  • Malnutrition acts as a bridge linking different symptom clusters, exacerbating overall symptom severity and impacting treatment outcomes.
Interpretation:

The study highlights the complex interplay between malnutrition and symptom clusters in NPC patients, suggesting that addressing malnutrition may improve quality of life and treatment outcomes, warranting further clinical exploration.

Limitations:
  • Cross-sectional design limits causal inferences.
  • Study conducted in a single center may affect generalizability.
  • Reliance on self-reported measures may introduce bias, potentially affecting data reliability.
Conclusion:

Integrating symptom clusters, nutritional status, and quality of life in a network framework can enhance understanding and management of treatment-related toxicities in NPC patients.

Original Source(s)

Related Content